A股異動丨新安股份漲4.52% 預計去年淨利潤增逾3倍 草甘膦市場價暴漲
格隆匯1月11日丨新安股份漲4.52%,報25.65元,總市值210億元。新安股份發佈業績預增公吿,預計2021年實現歸屬於上市公司股東的淨利潤26億元-27億元,同比增長344%~362%;扣非淨利潤也預計在26億元-27億元之間,同比增長548%至 574%。新安股份預計業績增長的原因包括草甘膦、有機硅、工業硅等在內的主要產品價格同比大幅上漲。草甘膦市場價從2020年第四季度以來一路暴漲,從2020年9月底的2.475萬元/噸一路漲至2021年底的8萬元/噸,漲幅超過2倍。其中,2021年第四季度,每噸漲價超過1萬元,年底市場價已創近十年新高。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.